PL2120890T3 - Peletki powlekane - Google Patents

Peletki powlekane

Info

Publication number
PL2120890T3
PL2120890T3 PL07856610T PL07856610T PL2120890T3 PL 2120890 T3 PL2120890 T3 PL 2120890T3 PL 07856610 T PL07856610 T PL 07856610T PL 07856610 T PL07856610 T PL 07856610T PL 2120890 T3 PL2120890 T3 PL 2120890T3
Authority
PL
Poland
Prior art keywords
coated pellets
lipophilic component
active ingredient
coated
vitro
Prior art date
Application number
PL07856610T
Other languages
English (en)
Inventor
Iris Ziegler
Irwin Jacobs
Original Assignee
Ds Tech Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ds Tech Gmbh filed Critical Ds Tech Gmbh
Publication of PL2120890T3 publication Critical patent/PL2120890T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
PL07856610T 2006-12-14 2007-12-12 Peletki powlekane PL2120890T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006059510A DE102006059510A1 (de) 2006-12-14 2006-12-14 Beschichtete Pellets
PCT/EP2007/010862 WO2008071407A2 (de) 2006-12-14 2007-12-12 Beschichtete pellets
EP07856610A EP2120890B1 (de) 2006-12-14 2007-12-12 Beschichtete pellets

Publications (1)

Publication Number Publication Date
PL2120890T3 true PL2120890T3 (pl) 2012-01-31

Family

ID=39272252

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07856610T PL2120890T3 (pl) 2006-12-14 2007-12-12 Peletki powlekane

Country Status (7)

Country Link
US (1) US8147874B2 (pl)
EP (1) EP2120890B1 (pl)
AT (1) ATE522204T1 (pl)
DE (1) DE102006059510A1 (pl)
ES (1) ES2369589T3 (pl)
PL (1) PL2120890T3 (pl)
WO (1) WO2008071407A2 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2268142T1 (sl) 2007-11-27 2017-09-29 Algipharma As Uporaba alginiranih oligomerov v boju proti biofilmom
CN102497883B (zh) 2009-06-03 2014-06-11 阿尔吉法玛公司 用于克服细菌多重抗药性的藻酸盐低聚物
US20110217426A1 (en) * 2010-03-04 2011-09-08 Perry Stephen C Enteric coating composition
EP2785200B1 (en) * 2011-11-28 2018-03-28 Tate & Lyle Ingredients Americas LLC Improved flavor natural tabletop sweetener
HUE033723T2 (en) 2013-04-12 2018-01-29 Hermes Arzneimittel Gmbh An oral pharmaceutical composition comprising N-acetyl cysteine in taste
JP6669646B2 (ja) * 2013-04-19 2020-03-18 デガマ スマート リミテッド 耐熱及び耐湿性プロバイオティクス細菌を含む顆粒を含む流動食
CN104116713B (zh) * 2013-04-24 2016-10-19 南京亿华药业有限公司 一种头孢地尼颗粒及其制备方法
WO2015193485A1 (en) 2014-06-20 2015-12-23 Hermes Arzneimittel Gmbh Taste-masked oral pharmaceutical composition
HUP1500164A2 (en) * 2015-04-14 2016-10-28 Ferenc Ecseri Filled straw with edible homogeneous structured granules and process for producing thereof
US11090702B2 (en) 2016-06-28 2021-08-17 Trustees Of Tufts College Compositions and methods for delivery of active agents
EP3558272A1 (en) 2016-12-23 2019-10-30 Hermes Arzneimittel GmbH Oral pharmaceutical composition with improved taste-masking properties
CN108904451A (zh) * 2018-07-27 2018-11-30 广州柏赛罗药业有限公司 缓释制剂
US20210169820A1 (en) 2019-09-12 2021-06-10 Nulixir Inc. Controlled release concentrate and suspensions including the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1594102A (en) * 1977-09-26 1981-07-30 Sankyo Co Ingestible coating compositions
US4341563A (en) * 1978-11-17 1982-07-27 Sankyo Company Limited Protective coating compositions
US4676236A (en) * 1983-09-09 1987-06-30 Gentex Corporation Helmet airflow system
JPS61174940A (ja) * 1985-01-29 1986-08-06 Oogawara Kakoki Kk ワックス類コーテイング単核状マイクロカプセルおよびその製造方法
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CA2407154A1 (en) * 2000-04-27 2001-11-01 Verion, Inc Zero order release and temperature-controlled microcapsules and process for the preparation thereof
DE10228175A1 (de) 2002-03-27 2003-10-09 Gruenenthal Gmbh Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen
DE10228179A1 (de) 2002-06-24 2004-01-22 Grünenthal GmbH Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen
DE10228171A1 (de) 2002-06-24 2004-01-22 Grünenthal GmbH Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen
DE10341264A1 (de) * 2003-09-04 2005-03-24 Grünenthal GmbH Schmelzformulierte, multipartikuläre orale Darreichungsform
DE10342513A1 (de) * 2003-09-12 2005-05-12 Gruenenthal Gmbh Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen, Kit und Verwendung
DE102005042875A1 (de) * 2004-12-23 2006-09-21 Grünenthal GmbH Schnell freisetzende Darreichungsformen für Antibiotika
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil

Also Published As

Publication number Publication date
US8147874B2 (en) 2012-04-03
EP2120890B1 (de) 2011-08-31
WO2008071407A2 (de) 2008-06-19
WO2008071407A3 (de) 2009-02-26
US20100068290A1 (en) 2010-03-18
EP2120890A2 (de) 2009-11-25
DE102006059510A1 (de) 2008-06-19
ATE522204T1 (de) 2011-09-15
ES2369589T3 (es) 2011-12-02

Similar Documents

Publication Publication Date Title
PL2120890T3 (pl) Peletki powlekane
NZ610701A (en) Once daily formulation of lacosamide
EP1786400A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE CONTROLLED RELEASE OF BIOLOGICAL ACTIVE SUBSTANCES
ATE531368T1 (de) Tacrolimus enthaltende zusammensetzungen mit modifizierter freisetzung
WO2010081824A3 (en) Active coating of pharmaceutical dosage forms
WO2006113631A3 (en) Bioenhanced compositions
TW200608975A (en) Pharmaceutical compositions
MY173730A (en) Orally-disintegrating solid preparation
MX2008000099A (es) Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones.
WO2009052171A3 (en) Controlled release remediation system and composition
WO2007084460A8 (en) Pharmaceutical compositions with enhanced stability
MX342439B (es) Metodos para producir nanoparticulas polimericas y formulaciones de ingredientes activos.
WO2010005732A3 (en) Composition and method of preparation of release systems for constant (zero-order) release of active agents
MX360389B (es) Formulacion farmaceutica o nutraceutica resistente a fluidos gastricos que comprende una o mas sales de acido alginico.
PL1713446T3 (pl) Nielamelarne trójskładnikowe kompozycje lipidów
WO2009034431A3 (en) Controlled-release dosage forms for varenicline
WO2010125323A8 (en) Biocidal composition
MX2009012856A (es) Composicion farmaceutica de liberacion lenta hecha de microparticulas.
WO2008113901A3 (fr) Composition à libération prolongée de lévétiracetam et procédé de préparation.
BG108870A (en) Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
WO2007100822A3 (en) Fluvastatin sodium pharmaceutical compositions
UA95224C2 (ru) Антацидная фармацевтическая композиция в порошковой форме, фармацевтическое средство, ее содержащее, и способ ее получения
WO2006096194A3 (en) Drinkable immediate release tablet made with direct compression of memantine or neramexane
ZA202208292B (en) Extended release plastic formulation
UA93530C2 (ru) Композиция c пролонгированным высвобождением активного вещества, способ ee получения и применения